Transducing properties of a pre-structured α-helical DPT-peptide containing a short canine adenovirus type 2 E4orf4

A Galioot1, A N Godet, V Maire

  • 1Unité Signalisation Moléculaire et Activation Cellulaire, Institut Pasteur, Paris, France.

Abstract

Insights

New DPT-E4orf44 peptides mimic adenoviral E4orf4 protein's anti-cancer signals by interacting with PP2A1 phosphatase. These peptides show potential as a scaffold for novel anti-cancer drug design.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Adenoviral E4orf4 protein interaction with PP2A1 phosphatase can induce cancer cell death pathways.
  • Developing therapies that mimic E4orf4's anti-cancer signaling is a promising strategy.
  • The DPT (Drug Penetrating Technology) concept utilizes peptides designed to interact with PP1/PP2A phosphatases.

Purpose of the Study:

  • To characterize new DPT-peptides designed to mimic the anti-cancer effects of adenoviral E4orf4.
  • To investigate the interaction of these peptides with PP2A1 phosphatase and their anti-cancer activity.

Main Methods:

  • Biochemical assays to study protein interactions.
  • Structural analysis to determine peptide conformation.
  • Cell survival experiments to assess anti-cancer efficacy.
  • Characterization of cell-penetrating peptides (DPT-E4orf44 and TAT-E4orf44).

Main Results:

  • Identified specific PP2A-binding sequences within the adenoviral E4orf4 N-terminal domain.
  • DPT-E4orf44, an α-helical peptide, effectively co-precipitated PP2A1 and inhibited cancer cell survival.
  • DPT-E4orf44 demonstrated superior internalization and anti-cancer activity compared to control peptides in various cancer cell lines, including HCT116.
  • Non-transformed fibroblasts remained unaffected by DPT-E4orf44 treatment.

Conclusions:

  • Characterized the transducing properties and PP2A-interacting capabilities of the novel DPT-E4orf44 peptide.
  • The α-helical structure and specific PP2A interaction of DPT peptides make them a promising scaffold for anti-cancer drug development.